LS007, a potent and orally bioavailable CDK9 inhibitor, suppresses the growth of triple-negative and estrogen receptor-positive breast cancer

被引：0
|
作者：
Rahaman, Muhammed Hamidur [1 ]
Zhang, Yinghui [1 ]
Islam, Md Saiful [1 ]
Heinemann, Gary [1 ]
Anshabo, Abel Tesfaye [1 ]
Albrecht, Hugo [1 ]
Milne, Robert [1 ]
Wang, Shudong [1 ]
机构：
[1] Univ South Australia, Adelaide, SA, Australia
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-4427
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4427
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Selective androgen receptor degraders for the treatment of androgen receptor-positive, triple-negative breast cancer.
    Asemota, Sarah
    Young, Kirsten Young
    Ponnusamy, Suriyan
    Thiyagarajan, Thirumagal
    Hwang, Dong-Jin
    He, Yali
    Breitmeyer, James B.
    Kaufmann, Gunnar F.
    Miller, Duane D.
    Narayanan, Ramesh
    CANCER RESEARCH, 2021, 81 (13)
  • [32] Anti-tumorigenic effects of a novel digitoxin derivative on both estrogen receptor-positive and triple-negative breast cancer cells
    Kulkarni, Yogesh M.
    Yakisich, Juan S.
    Azad, Neelam
    Venkatadri, Rajkumar
    Kaushik, Vivek
    O'Doherty, George
    Iyer, Anand Krishnan V.
    TUMOR BIOLOGY, 2017, 39 (06)
  • [33] Active Smoking and the Risk of Estrogen Receptor-Positive and Triple-Negative Breast Cancer Among Women Ages 20 to 44 Years
    Kawai, Masaaki
    Malone, Kathleen E.
    Tang, Mei-Tzu C.
    Li, Christopher I.
    CANCER, 2014, 120 (07) : 1026 - 1034
  • [34] A kinase inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast cancer to EGFR-targeted therapy
    Ronan P. McLaughlin
    Jichao He
    Vera E. van der Noord
    Jevin Redel
    John A. Foekens
    John W. M. Martens
    Marcel Smid
    Yinghui Zhang
    Bob van de Water
    Breast Cancer Research, 21
  • [35] Single Hormone Receptor-Positive Metaplastic Breast Cancer: Similar Outcome as Triple-Negative Subtype
    Mao, Jinqian
    Hu, Jin
    Zhang, Yanting
    Shen, Jian
    Dong, Fang
    Zhang, Ximeng
    Ming, Jie
    Huang, Tao
    Run, Xiaoqin
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [36] Tumor-infiltrating lymphocytes in androgen receptor-positive, triple-negative breast cancer.
    Leon-Ferre, Roberto Antonio
    Polley, Mei-Yin
    Liu, Heshan
    Cafourek, Victoria
    Boughey, Judy Caroline
    Kalari, Krishna R.
    Negron, Vivian
    Liu, Minetta C.
    Ingle, James N.
    Couch, Fergus
    Visscher, Daniel W.
    Goetz, Matthew P.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (05)
  • [37] A kinase inhibitor screen identifies a dual cdc7/CDK9 inhibitor to sensitise triple-negative breast cancer to EGFR-targeted therapy
    McLaughlin, Ronan P.
    He, Jichao
    van der Noord, Vera E.
    Redel, Jevin
    Foekens, John A.
    Martens, John W. M.
    Smid, Marcel
    Zhang, Yinghui
    van de Water, Bob
    BREAST CANCER RESEARCH, 2019, 21 (1)
  • [38] A Targetable Androgen Receptor-Positive Breast Cancer Subtype Hidden Among the Triple-Negative Cancers
    Safarpour, Damoun
    Tavassoli, Fattaneh A.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2015, 139 (05) : 612 - 617
  • [39] Targeting the USP7-CDK1 axis suppresses estrogen receptor-positive breast cancer progression
    Lin, Joseph
    Lin, Yueh-Te
    Hsu, Kai-Wen
    Liu, Yi-En
    Chen, Yun-Cen
    Yeh, Yung-Liang
    Huang, Hsin-Ya
    Hsieh, Chang-Chi
    Chen, Dar-Ren
    Wu, Han-Tsang
    CANCER CELL INTERNATIONAL, 2025, 25 (01)
  • [40] Discovery of a potent inhibitor of CREB-mediated gene transcription that completely suppresses the growth of triple-negative breast cancer cells
    Xiao, X.
    Li, B.
    Xie, F.
    Fan, Q.
    Xue, C.
    Qian, D.
    CANCER RESEARCH, 2013, 73
12345